Manufacturing

Genomic Health asserted the U.S commercial launch of  Oncotype DX AR-V7 Nucleus Detect test. The Oncotype DX AR-V7 Nucleus Detect test was developed by Epic Sciences to help prolong the…
Read More...

Leading innovator in  treatments for atrial fibrillation (Afib), AtriCure and left atrial appendage management (LAAM) announced the rolling out of AtriClip FLEX•V Left Atrial Appendage…
Read More...

McKesson Specialty Health oncology and complex care pharmacy services company has been finalized by the Janssen Pharmaceutical Companies of Johnson & Johnson which is considered the…
Read More...

Rubius Therapeutics asserted the appointment of Spencer Fisk as Senior Vice-President, Manufacturing. Rubius Therapeutics is a biotechnology company endeavoring the creation of a new…
Read More...

GenePOC asserted the launch of GenePOC GBS LB assay which is implied to be in its home market for the revogene instrument. The revogene is an automated stand-alone instrument that…
Read More...

Intralytix proclaimed having sought Food and Drug Administration's clearance to commence Phase I/IIa Clinical Trials at Mount Sinai hospital in New York. Dating back to July,2015,…
Read More...

Regentys, a regenerative medicine company, announced it will partner with Cook Biotech Inc., collaborate to develop a novel treatment for ulcerative colitis.Cook Biotech will develop…
Read More...

ImmunoQure will collaborate with Servier to advance ImmunoQure's therapeutic human Interferon-α autoantibody through preclinical development and into the clinic where Servier will be…
Read More...

OTTR, the leading provider of organ transplant patient tracking software that improves the quality of patient care via workflow management, has partnered with Hemasoft, an international…
Read More...

Novartis division, Sandoz asserted that the US FDA ha sanctioned the roll out and launch of Glatopa (glatiramer acetate injection) 40 mg/mL. Glatopa was developed under a…
Read More...

LakePharma announced the launch of the LakePharma MicroBiomanufacturing (GMP) Center in Hopkinton, MA. Located at 35 South Street, the newly-acquired 69,000-square foot building…
Read More...

Wuxi Biologics and Aravive Biologics collaborate to extend their biologics manufacturing collaboration, based on the rapid success achieved in the process development, scale-up and cGMP…
Read More...

Sterling Pharma Solutions witnessed growth in the Japanese market owing to its technical capabilities and innovation strategy. Sterling's technology and innovation strategy, which has…
Read More...

Avista Pharma Solutions completed acquisition of  Solid Form Solutions located in Edinburgh, Scotland. Solid Form Solutions provider of solid state chemistry and crystallization…
Read More...

APRINOIA Therapeutics into  tau, alpha-synuclein, and novel targets for neurodegenerative diseases declared the completion of its US$11.1 million Series B round to finance preclinical…
Read More...

Sarah Cannon Research Institute and South Texas Research Accelerated Therapeutics moved to collaborate ensuring augmenting their globally acclaimed phase I drug development programs…
Read More...

Antibody discovery and optimization service provider, AvantGen claimed completion of its first cancer therapeutic antibody program in collaboration with Tanabe Research Laboratories USA…
Read More...

U.S Stem Cell, Inc. claimed to be a leader in the development of proprietary stem cell therapies asserted accomplishing the target of 10,000 kit sales of proprietary Adipocell product,…
Read More...

Adaptimmune Therapeutics embarks on manufacturing T-cell therapy to treat  cancer entitled SPEAR T-cells for a patient at its Navy Yard facility in Philadelphia. In addition to this…
Read More...

Celgene Corporation and Impact Biomedicinessigned and agreement that entails acquisition of Impact Biomedicines enabling development of fedratinib  for myelofibrosis and polycythemia…
Read More...